{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:46:14Z","timestamp":1792125974400,"version":"4.4.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Rep."],"DOI":"10.1186\/s41824-026-00327-2","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:08:18Z","timestamp":1792123698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNA damage in thyroid cancer patients treated with radioactive iodine in Johannesburg, South Africa"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-3924","authenticated-orcid":false,"given":"Shingirai Brenda","family":"Kagodora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans","family":"Baeyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mboyo","family":"Di Tamba\u00a0Willy\u00a0Vangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"8002","key":"327_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-023-07009-0","volume":"627","author":"DJ Adams","year":"2024","unstructured":"Adams DJ, Barlas B, McIntyre RE, Salguero I, Van Der Weyden L, Barros A et al (2024) Genetic determinants of micronucleus formation in vivo. Nature 627(8002):130\u2013136","journal-title":"Nature"},{"issue":"3","key":"327_CR72","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00580-012-1671-7","volume":"23","author":"AHM Alfaisal","year":"2014","unstructured":"Alfaisal AHM, Al-Ramahi IJK, Abdul-Hassan IAR (2014) Micronucleus frequency among Iraqi thyroid disorder patients. Comp Clin Pathol 23(3):683\u2013688","journal-title":"Comp Clin Pathol"},{"issue":"12","key":"327_CR28","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/sj.bjc.6600628","volume":"87","author":"A Baeyens","year":"2002","unstructured":"Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L et al (2002) Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87(12):1379\u20131385","journal-title":"Br J Cancer"},{"issue":"7","key":"327_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JT, Khan AA (2015) KJ. H. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15(7):409\u2013425","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"327_CR62","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2307\/3579122","volume":"140","author":"L Baugnet-Mahieu","year":"1994","unstructured":"Baugnet-Mahieu L, Lemaire M, L\u00e9onard ED, L\u00e9onard A, Gerber GB (1994) Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res 140(3):429\u2013431","journal-title":"Radiat Res"},{"issue":"4","key":"327_CR59","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1158\/1055-9965.EPI-18-0877","volume":"28","author":"EL Bolf","year":"2019","unstructured":"Bolf EL, Sprague BL, Carr FE (2019) A Linkage Between Thyroid and Breast Cancer: A Common Etiology? Cancer Epidemiology. Biomarkers Prev 28(4):643\u2013649","journal-title":"Biomarkers Prev"},{"issue":"6","key":"327_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1210\/er.2012-1030","volume":"33","author":"SJ Bonnema","year":"2012","unstructured":"Bonnema SJ, Hegedus L (2012) Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev 33(6):920\u2013980","journal-title":"Endocr Rev"},{"issue":"1","key":"327_CR24","doi-asserted-by":"publisher","first-page":"27043","DOI":"10.1038\/srep27043","volume":"6","author":"M Borr\u00e0s-Fresneda","year":"2016","unstructured":"Borr\u00e0s-Fresneda M, Barquinero J-F, Gomolka M, Hornhardt S, R\u00f6ssler U, Armengol G et al (2016) Differences in DNA Repair Capacity, Cell Death and Transcriptional Response after Irradiation between a Radiosensitive and a Radioresistant Cell Line. Sci Rep 6(1):27043","journal-title":"Sci Rep"},{"issue":"9","key":"327_CR5","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/genes11091039","volume":"11","author":"S-H Byun","year":"2020","unstructured":"Byun S-H, Min C, Choi H-G, Hong S-J (2020) Association between Family Histories of Thyroid Cancer and Thyroid Cancer Incidence: A Cross-Sectional Study Using the Korean Genome and Epidemiology Study Data. Genes 11(9):1039","journal-title":"Genes"},{"issue":"10061","key":"327_CR16","first-page":"2783","volume":"388","author":"ME Cabanillas","year":"2016","unstructured":"Cabanillas ME, McFadden DG (2016) C D Thyroid cancer Lancet 388(10061):2783\u20132795","journal-title":"C D Thyroid cancer Lancet"},{"key":"327_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/2041-9414.198906","volume":"8","author":"A Cebulska-Wasilewska","year":"2017","unstructured":"Cebulska-Wasilewska A, Krzysiek M, Krajewska G, Stepien A, Krajewski P (2017) Retrospective Biological Dosimetry at Low and High Doses of Radiation and Radioiodine Impact on Individual Susceptibility to Ionizing Radiation. Genome Integr 8:2","journal-title":"Genome Integr"},{"issue":"2","key":"327_CR36","first-page":"553","volume":"12","author":"VB Ch\u00e1ves-Campos Andr\u00e9s","year":"2022","unstructured":"Ch\u00e1ves-Campos Andr\u00e9s VB, Luisa (2022) Malesp\u00edn-Benda\u00f1a Wendy, Vanessa. R-M. Ensayo de micron\u00facleos con bloqueo de la citocinesis como biomarcador de da\u00f1o gen\u00e9tico en poblaciones sobreexpuestas a radiaciones ionizantes. PSM 12(2):553\u2013572","journal-title":"PSM"},{"issue":"2","key":"327_CR66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ecl.2021.11.017","volume":"51","author":"DW Chen","year":"2022","unstructured":"Chen DW, Yeh MW (2022) Disparities in Thyroid Care. Endocrinol Metab Clin North Am 51(2):229\u2013241","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"327_CR54","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0301-472X(02)00802-0","volume":"30","author":"N Dainiak","year":"2002","unstructured":"Dainiak N (2002) Hematologic consequences of exposure to ionizing radiation. Exp Hematol 30(6):513\u2013528","journal-title":"Exp Hematol"},{"issue":"10","key":"327_CR26","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1038\/sj.bjc.6604345","volume":"98","author":"K De Ruyck","year":"2008","unstructured":"De Ruyck K, De Gelder V, Van Eijkeren M, Boterberg T, De Neve W, Vral A et al (2008) Chromosomal radiosensitivity in head and neck cancer patients: evidence for genetic predisposition? Br J Cancer 98(10):1723\u20131728","journal-title":"Br J Cancer"},{"issue":"4","key":"327_CR68","first-page":"351","volume":"119","author":"J Dedon","year":"2022","unstructured":"Dedon J (2022) Thyroid Disease in Aging. Mo Med 119(4):351\u2013353","journal-title":"Mo Med"},{"issue":"1","key":"327_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/mutage\/geq076","volume":"26","author":"VS Dhillon","year":"2011","unstructured":"Dhillon VS, Thomas P, Iarmarcovai G, Kirsch-Volders M, Bonassi S, Fenech M (2011) Genetic polymorphisms of genes involved in DNA repair and metabolism influence micronucleus frequencies in human peripheral blood lymphocytes. Mutagenesis 26(1):33\u201342","journal-title":"Mutagenesis"},{"issue":"2","key":"327_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.11106\/ijt.2020.13.2.95","volume":"13","author":"V Drozd","year":"2020","unstructured":"Drozd V, Branovan DI, Reiners C (2020) Increasing Incidence of Thyroid Carcinoma: Risk Factors and Seeking Approaches for Primary Prevention. Int J Thyroidol 13(2):95\u2013110","journal-title":"Int J Thyroidol"},{"key":"327_CR29","doi-asserted-by":"crossref","unstructured":"Durante M, Formenti SC (2018) Radiation-induced chromosomal aberrations and immunotherapy: micronuclei, cytosolic DNA, and interferon-production pathway. Front Oncol. 8","DOI":"10.3389\/fonc.2018.00192"},{"key":"327_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-1-59745-548-0_12","volume":"410","author":"M Fenech","year":"2008","unstructured":"Fenech M (2008) The micronucleus assay determination of chromosomal level DNA damage. Methods Mol Biol 410:185\u2013216","journal-title":"Methods Mol Biol"},{"issue":"1","key":"327_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/mutage\/geq050","volume":"26","author":"M Fenech","year":"2011","unstructured":"Fenech M, Bonassi S (2011) The effect of age, gender, diet and lifestyle on DNA damage measured using micronucleus frequency in human peripheral blood lymphocytes. Mutagenesis 26(1):43\u201349","journal-title":"Mutagenesis"},{"key":"327_CR34","doi-asserted-by":"crossref","unstructured":"Fenech M, Knasmueller S, Bolognesi C, Holland N, Bonassi S, M. K-V.(2020) Micronuclei as biomarkers of DNA damage, aneuploidy, inducers of chromosomal hypermutation and as sources of pro-inflammatory DNA in humans. Mutat Res Rev Mutat Res. 786","DOI":"10.1016\/j.mrrev.2020.108342"},{"issue":"S1","key":"327_CR21","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.21037\/gs.2017.11.07","volume":"7","author":"SM Ferrari","year":"2018","unstructured":"Ferrari SM, Fallahi P, Ruffilli I, Elia G, Ragusa F, Paparo SR et al (2018) Molecular testing in the diagnosis of differentiated thyroid carcinomas. Gland Surg 7(S1):S19\u2013S29","journal-title":"Gland Surg"},{"issue":"1","key":"327_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/mutage\/15.1.69","volume":"15","author":"OM Gil","year":"2000","unstructured":"Gil OM (2000) Cytogenetic alterations and oxidative stress in thyroid cancer patients after iodine-131 therapy. Mutagenesis 15(1):69\u201375","journal-title":"Mutagenesis"},{"issue":"23","key":"327_CR45","doi-asserted-by":"publisher","first-page":"12564","DOI":"10.3390\/app132312564","volume":"13","author":"A Gkikoudi","year":"2023","unstructured":"Gkikoudi A, Kalospyros SA, Triantopoulou S, Logotheti S, Softa V, Kappas C et al (2023) Molecular Biomarkers for Predicting Cancer Patient Radiosensitivity and Radiotoxicity in Clinical Practice. Appl Sci 13(23):12564","journal-title":"Appl Sci"},{"issue":"2","key":"327_CR71","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/mutage\/14.2.221","volume":"14","author":"S Gutierrez","year":"1999","unstructured":"Gutierrez S, Carbonell E, Galofre P, Creus A, Marcos R (1999) Low sensitivity of the sister chromatid exchange assay to detect the genotoxic effects of radioiodine therapy. Mutagenesis 14(2):221\u2013226","journal-title":"Mutagenesis"},{"issue":"4","key":"327_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/j.2205-0140.2010.tb00177.x","volume":"13","author":"J Hoang","year":"2010","unstructured":"Hoang J (2010) Thyroid nodules and evaluation of thyroid cancer risk. Australasian J Ultrasound Med 13(4):33\u201336","journal-title":"Australasian J Ultrasound Med"},{"issue":"4","key":"327_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s13139-018-0522-0","volume":"52","author":"CM Hong","year":"2018","unstructured":"Hong CM, Ahn BC (2018) Factors Associated with Dose Determination of Radioactive Iodine Therapy for Differentiated Thyroid Cancer. Nucl Med Mol Imaging 52(4):247\u2013253","journal-title":"Nucl Med Mol Imaging"},{"issue":"4","key":"327_CR48","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.path.2019.08.004","volume":"12","author":"J Huang","year":"2019","unstructured":"Huang J, Harris EJ, Lorch JH (2019) Treatment of Aggressive Thyroid Cancer. Surg Pathol Clin 12(4):943\u2013950","journal-title":"Surg Pathol Clin"},{"key":"327_CR69","doi-asserted-by":"publisher","first-page":"e54891","DOI":"10.2196\/54891","volume":"13","author":"Y Huang","year":"2024","unstructured":"Huang Y, Chen S, Wang Y, Ou X, Yan H, Gan X et al (2024) Analyzing Comorbidity Patterns in Patients With Thyroid Disease Using Large-Scale Electronic Medical Records: Network-Based Retrospective Observational Study. Interact J Med Res 13:e54891","journal-title":"Interact J Med Res"},{"key":"327_CR75","first-page":"32","volume":"765","author":"K Huumonen","year":"2014","unstructured":"Huumonen K, Korkalainen M, Boman E, Heikkil\u00e4 J, H\u00f6yt\u00f6 A, Lahtinen T et al (2014) Dose- and time-dependent changes of micronucleus frequency and gene expression in the progeny of irradiated cells: two components in radiation-induced genomic instability? Mutat Res 765:32\u201339","journal-title":"Mutat Res"},{"issue":"19","key":"327_CR50","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1002\/cncr.26070","volume":"117","author":"NG Iyer","year":"2011","unstructured":"Iyer NG, Morris LGT, Tuttle RM, Shaha AR, Ganly I (2011) Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer 117(19):4439\u20134446","journal-title":"Cancer"},{"key":"327_CR32","doi-asserted-by":"crossref","unstructured":"Jarosz-Biej M, Smolarczyk R, Cicho\u0144 T, N. K. (2019) Tumor microenvironment as a game changer in cancer radiotherapy. Int J Mol Sci. 20(13)","DOI":"10.3390\/ijms20133212"},{"issue":"12","key":"327_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3109\/09553000903261263","volume":"85","author":"P Jeggo","year":"2009","unstructured":"Jeggo P, Lavin MF (2009) Cellular radiosensitivity: how much better do we understand it? Int J Radiat Biol 85(12):1061\u20131081","journal-title":"Int J Radiat Biol"},{"key":"327_CR12","doi-asserted-by":"crossref","unstructured":"Christofer Juhlin C, Mete O (2023) ZW. B. The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr Relat Cancer. 30(2)","DOI":"10.1530\/ERC-22-0293"},{"key":"327_CR3","doi-asserted-by":"crossref","unstructured":"Christofer Juhlin C, Mete O, Baloch ZW (2023) The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr Relat Cancer. 30(2)","DOI":"10.1530\/ERC-22-0293"},{"key":"327_CR76","doi-asserted-by":"publisher","first-page":"102673","DOI":"10.1016\/j.dnarep.2019.102673","volume":"83","author":"J Kay","year":"2019","unstructured":"Kay J, Thadhani E, Samson L, Engelward B (2019) Inflammation-induced DNA damage, mutations and cancer. DNA Repair (Amst) 83:102673","journal-title":"DNA Repair (Amst)"},{"issue":"6","key":"327_CR56","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/jnci\/djad040","volume":"115","author":"KJ Kim","year":"2023","unstructured":"Kim KJ, Kim KJ, Choi J, Kim NH, Kim SG (2023) Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer. JNCI: J Natl Cancer Inst 115(6):695\u2013702","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"5","key":"327_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1590\/S0004-27302007000500007","volume":"51","author":"M Knobel","year":"2007","unstructured":"Knobel M, Medeiros-Neto G (2007) Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arquivos Brasileiros de Endocrinologia Metabologia 51(5):701\u2013712","journal-title":"Arquivos Brasileiros de Endocrinologia Metabologia"},{"key":"327_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ceb.2021.01.004","volume":"70","author":"K Krupina","year":"2021","unstructured":"Krupina K, Goginashvili A, Cleveland DW (2021) Causes and consequences of micronuclei. Curr Opin Cell Biol 70:91\u201399","journal-title":"Curr Opin Cell Biol"},{"key":"327_CR22","unstructured":"Little JB (2003) Principal Cellular and Tissue Effects of Radiation. In: Holland-Frei Cancer Medicine [Internet]. Hamilton BC Decker. 6th. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK12344\/"},{"key":"327_CR31","doi-asserted-by":"crossref","unstructured":"Liu Q, Sun W (2022) H. Z. Roles and new insights of macrophages in the tumor microenvironment of thyroid cancer. Front Pharmacol. 13(875384)","DOI":"10.3389\/fphar.2022.875384"},{"key":"327_CR70","doi-asserted-by":"crossref","unstructured":"Cararo Lopes E, Sawant A, Moore D, Ke H, Shi F, Laddha S et al (2023) Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer. Clin Translational Med 13(6)","DOI":"10.1002\/ctm2.1298"},{"issue":"20","key":"327_CR60","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.3390\/cancers14205117","volume":"14","author":"M Lu","year":"2022","unstructured":"Lu M, Liu H, Zheng B, Sun S, Chen C (2022) Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions. Cancers 14(20):5117","journal-title":"Cancers"},{"key":"327_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fgene.2013.00131","volume":"4","author":"L Luzhna","year":"2013","unstructured":"Luzhna L, Kathiria P, Kovalchuk O (2013) Micronuclei in genotoxicity assessment: from genetics to epigenetics and beyond. Front Genet 4:131","journal-title":"Front Genet"},{"issue":"11","key":"327_CR61","first-page":"1860","volume":"37","author":"R M\u2019Kacher","year":"1996","unstructured":"M\u2019Kacher R, Legal JD, Schlumberger M, Voisin P, Aubert B, Gaillard N et al (1996) Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 37(11):1860\u20131864","journal-title":"J Nucl Med"},{"issue":"4","key":"327_CR52","doi-asserted-by":"publisher","first-page":"e1885","DOI":"10.1371\/journal.pone.0001885","volume":"3","author":"HO M\u00e4enp\u00e4\u00e4","year":"2008","unstructured":"M\u00e4enp\u00e4\u00e4 HO, Heikkonen J, Vaalavirta L, Tenhunen M, Joensuu H (2008) Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study. PLoS ONE 3(4):e1885","journal-title":"PLoS ONE"},{"issue":"5","key":"327_CR41","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1042\/EBC20200016","volume":"64","author":"M MacDonald Kate","year":"2020","unstructured":"MacDonald Kate M, Benguerfi S, Harding Shane M (2020) Alerting the immune system to DNA damage: micronuclei as mediators. Essays Biochem 64(5):753\u2013764","journal-title":"Essays Biochem"},{"issue":"6","key":"327_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/17446651.2022.2144832","volume":"17","author":"A Matrone","year":"2022","unstructured":"Matrone A (2022) Risk factors in thyroid cancer: is the obesity pandemic an important factor? Expert Rev Endocrinol Metabolism 17(6):463\u2013466","journal-title":"Expert Rev Endocrinol Metabolism"},{"issue":"50","key":"327_CR65","doi-asserted-by":"publisher","first-page":"e2193","DOI":"10.1097\/MD.0000000000002193","volume":"94","author":"Z Meng","year":"2015","unstructured":"Meng Z, Liu M, Zhang Q, Liu L, Song K, Tan J et al (2015) Gender and Age Impacts on the Association Between Thyroid Function and Metabolic Syndrome in Chinese. Med (Baltim) 94(50):e2193","journal-title":"Med (Baltim)"},{"key":"327_CR67","doi-asserted-by":"crossref","unstructured":"Mhlanga D, R. G.(2020) The Influence of Racial Differences in the Demand for Healthcare in South Africa: A Case of Public Healthcare. Int J Environ Res Public Health. 17(14)","DOI":"10.3390\/ijerph17145043"},{"key":"327_CR33","doi-asserted-by":"publisher","first-page":"108712","DOI":"10.1016\/j.ejrad.2019.108712","volume":"121","author":"J Miszczyk","year":"2019","unstructured":"Miszczyk J, Rawojc K, Panek A, Galas A, Kowalska A, Szczodry A et al (2019) Assessment of the nuclear medicine personnel occupational exposure to radioiodine. Eur J Radiol 121:108712","journal-title":"Eur J Radiol"},{"issue":"6","key":"327_CR46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/ijc.10768","volume":"102","author":"O Monteiro Gil","year":"2002","unstructured":"Monteiro Gil O, Oliveira NG, Rodrigues AS, Laires A, Ferreira TC, Limbert E et al (2002) Possible transient adaptive response to mitomycin C in peripheral lymphocytes from thyroid cancer patients after iodine-131 therapy. Int J Cancer 102(6):556\u2013561","journal-title":"Int J Cancer"},{"key":"327_CR17","doi-asserted-by":"crossref","unstructured":"Nagaiah G, Hossain A, Mooney CJ, Parmentier J (2011) SC. R. Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol","DOI":"10.1155\/2011\/542358"},{"issue":"S2","key":"327_CR20","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1038\/modpathol.2008.10","volume":"21","author":"YE Nikiforov","year":"2008","unstructured":"Nikiforov YE (2008) Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol 21(S2):S37\u2013S43","journal-title":"Mod Pathol"},{"issue":"3","key":"327_CR74","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/0972-3919.183621","volume":"31","author":"A \u00d6zdal","year":"2016","unstructured":"\u00d6zdal A, Erselcan T, \u00d6zdemir \u00d6, Silov G, Erdo\u011fan Z, Turhal \u00d6 (2016) Micronucleus frequencies in groups receiving external or internal radiation. Indian J Nucl Med 31(3):179\u2013184","journal-title":"Indian J Nucl Med"},{"issue":"13","key":"327_CR55","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1200\/JCO.21.01841","volume":"40","author":"E Pasqual","year":"2022","unstructured":"Pasqual E, Schonfeld S, Morton LM, Villoing D, Lee C, De Berrington A et al (2022) Association Between Radioactive Iodine Treatment for Pediatric and Young Adulthood Differentiated Thyroid Cancer and Risk of Second Primary Malignancies. J Clin Oncol 40(13):1439\u20131449","journal-title":"J Clin Oncol"},{"issue":"8","key":"327_CR27","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1054\/bjoc.2001.2086","volume":"85","author":"AC Riches","year":"2001","unstructured":"Riches AC, Bryant PE, Steel CM, Gleig A, Robertson AJ, Preece PE et al (2001) Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics. Br J Cancer 85(8):1157\u20131161","journal-title":"Br J Cancer"},{"issue":"2","key":"327_CR13","doi-asserted-by":"publisher","first-page":"2473974X1877723","DOI":"10.1177\/2473974X18777238","volume":"2","author":"LL Sakafu","year":"2018","unstructured":"Sakafu LL, Mselle TF, Mwaiselage JD, Maunda KK, Eddin BS, Zafereo ME (2018) Thyroid Cancer and Iodine Deficiency Status: A 10-Year Review at a Single Cancer Center in Tanzania. OTO Open 2(2):2473974X1877723","journal-title":"OTO Open"},{"key":"327_CR73","doi-asserted-by":"crossref","unstructured":"Santos LS, Gil OM, Silva SN, Gomes BC, Ferreira TC, Limbert E, et al (2020) Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants. Genes (Basel). 11(9)","DOI":"10.3390\/genes11091083"},{"issue":"9","key":"327_CR11","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/genes11091083","volume":"11","author":"S Santos","year":"2020","unstructured":"Santos S, Gil LM, Silva ON, Gomes SC, Ferreira BC, Limbert T (2020) Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants. Genes 11(9):1083","journal-title":"Genes"},{"issue":"5","key":"327_CR57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1089\/thy.2008.0392","volume":"19","author":"AM Sawka","year":"2009","unstructured":"Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD et al (2009) Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 19(5):451\u2013457","journal-title":"Thyroid"},{"issue":"6","key":"327_CR49","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/ijms18061292","volume":"18","author":"B Schmidbauer","year":"2017","unstructured":"Schmidbauer B, Menhart K, Hellwig D, Grosse J (2017) Differentiated Thyroid Cancer\u2014Treatment: State of the Art. Int J Mol Sci 18(6):1292","journal-title":"Int J Mol Sci"},{"issue":"1","key":"327_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s13193-021-01429-y","volume":"13","author":"JB Shank","year":"2022","unstructured":"Shank JB, Are C, Wenos CD (2022) Thyroid Cancer: Global Burden and Trends. Indian J Surg Oncol 13(1):40\u201345","journal-title":"Indian J Surg Oncol"},{"issue":"9356","key":"327_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","volume":"361","author":"SI Sherman","year":"2003","unstructured":"Sherman SI (2003) Thyroid carcinoma. Lancet 361(9356):501\u2013511","journal-title":"Lancet"},{"issue":"10","key":"327_CR64","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2967\/jnumed.121.263442","volume":"63","author":"A Signore","year":"2022","unstructured":"Signore A, Campagna G, Marinaccio J, Vitis M, Lauri C, Berardinelli F et al (2022) Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with (131)I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant Ablation. J Nucl Med 63(10):1515\u20131522","journal-title":"J Nucl Med"},{"key":"327_CR38","doi-asserted-by":"crossref","unstructured":"Sommer S, Buraczewska I, Kruszewski M (2020) Micronucleus assay: the state of art, and future directions. Int J Mol Sci 21(4)","DOI":"10.3390\/ijms21041534"},{"issue":"10","key":"327_CR58","first-page":"1142","volume":"36","author":"S Teng","year":"2015","unstructured":"Teng S, Jia Q, Huang Y, Chen L, Fei X, Wu J (2015) [Hierarchical regionalization for spatial epidemiology: a case study of thyroid cancer incidence in Yiwu, Zhejiang]. Zhonghua Liu Xing Bing Xue Za Zhi 36(10):1142\u20131147","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"7","key":"327_CR15","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3390\/cancers13071625","volume":"13","author":"EA Toraih","year":"2021","unstructured":"Toraih EA, Hussein MH, Zerfaoui M, Attia AS, Marzouk Ellythy A, Mostafa A et al (2021) Site-Specific Metastasis and Survival in Papillary Thyroid Cancer: The Importance of Brain and Multi-Organ Disease. Cancers 13(7):1625","journal-title":"Cancers"},{"issue":"10","key":"327_CR23","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1210\/jc.2002-020339","volume":"87","author":"N Wada","year":"2002","unstructured":"Wada N, Duh Q-Y, Miura D, Brunaud L, Wong MG, Clark OH (2002) Chromosomal Aberrations by Comparative Genomic Hybridization in H\u00fcrthle Cell Thyroid Carcinomas Are Associated with Tumor Recurrence. J Clin Endocrinol Metabolism 87(10):4595\u20134601","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"5","key":"327_CR53","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21689","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang K, Tepper JE (2021) Radiation therapy-associated toxicity: Etiology, management, and prevention. Cancer J Clin 71(5):437\u2013454","journal-title":"Cancer J Clin"},{"issue":"10","key":"327_CR10","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1002\/cam4.5698","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang Q, Shao X, Zhang Y, Zhu M, Wang FXC, Mu J et al (2023) Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med 12(10):11149\u201311165","journal-title":"Cancer Med"},{"issue":"3","key":"327_CR63","first-page":"436","volume":"39","author":"N Watanabe","year":"1998","unstructured":"Watanabe N, Yokoyama K, Kinuya S, Shuke N, Shimizu M, Futatsuya R et al (1998) Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay. J Nucl Med 39(3):436\u2013440","journal-title":"J Nucl Med"},{"issue":"3","key":"327_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing M (2013) Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 13(3):184\u2013199","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"327_CR4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/cncr.26398","volume":"118","author":"L Xu","year":"2012","unstructured":"Xu L, Li G, Wei Q, El-Naggar AK, Sturgis EM (2012) Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer 118(5):1228\u20131235","journal-title":"Cancer"}],"container-title":["EJNMMI Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-026-00327-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-026-00327-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41824-026-00327-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:08:21Z","timestamp":1792123701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41824-026-00327-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1186\/s41824-026-00327-2","relation":{},"ISSN":["3005-074X"],"issn-type":[{"value":"3005-074X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received ethics approval from Wits University Human Research ethics committee certificate M1909107. Participants gave informed consent to confirm that they had been informed about the nature, conduct, benefits of the study on chromosomal aberrations and radioactive iodine treatment in thyroid cancer patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors consent to publication of this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict and competition of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"42"}}